Pharmeasy-parent’s loss narrows in Q1, revenue up 10%
API Holdings, parent of PharmEasy and Thyrocare, narrowed its Q1 FY27 loss to Rs 29.6 crore from Rs 145.4 crore a year earlier, while revenue grew 10% to Rs 1,754 crore. Ebitda turned positive at Rs 39.3 crore. The company also became debt-free after repaying Rs 1,050 crore.
The parent company of Pharmeasy and Thyrocare, API Holdings, reported narrower financial losses and increased revenue in Q1 FY27. The company's loss narrowed to Rs 29.6 crore in Q1, from Rs 145.4 crore in the previous year, while its Ebitda rose to Rs 39.3 crore, compared to a loss of Rs 12.8 crore in the prior quarter. API Holdings repaid Rs 1,050 crore of outstanding debt, marking the company as debt-free.
Revenue for the quarter grew by 10% to Rs 1,754 crore, driven by B2B and consumer businesses. Pharmeasy, an online pharmacy app, reported a 10% revenue increase to Rs 348 crore, with Ebitda narrowing to Rs 17 crore, down from Rs 21 crore a year ago.
Written by urgent.news from Economic Times Tech's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
